메뉴 건너뛰기




Volumn 13, Issue 3, 2009, Pages 336-341

Putting evidence into practice: Evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 69449108576     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/09.CJON.336-341     Document Type: Article
Times cited : (29)

References (26)
  • 1
    • 79953110335 scopus 로고    scopus 로고
    • Coping with the side effects of cancer treatment on your nutritional status
    • American Institute of Cancer Research, Retrieved September 23, 2007, from
    • American Institute of Cancer Research. (2009). Coping with the side effects of cancer treatment on your nutritional status. Retrieved September 23, 2007, from http://www.aicr.org/site/PageServer?pagename=dc_cr_treatment#nutrition
    • (2009)
  • 4
    • 79953087320 scopus 로고    scopus 로고
    • Eastern Cooperative Oncology Group, Retrieved November 15, 2007, from
    • Eastern Cooperative Oncology Group. (2007). ECOG common toxicity criteria. Retrieved November 15, 2007, from http://www.ecog.org/general/ctc.pdf
    • (2007) ECOG Common Toxicity Criteria
  • 6
    • 65549158116 scopus 로고    scopus 로고
    • Enterotoxicity of chemotherapeutic agents
    • Retrieved September 10, 2007, from
    • Halmos, B. (2007). Enterotoxicity of chemotherapeutic agents. Retrieved September 10, 2007, from http://www.uptodate.com
    • (2007)
    • Halmos, B.1
  • 7
    • 0032144529 scopus 로고    scopus 로고
    • Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients
    • Ippoliti, C. (1998). Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients. American Journal of Health-System Pharmacy, 55(15), 1573-1580.
    • (1998) American Journal of Health-System Pharmacy , vol.55 , Issue.15 , pp. 1573-1580
    • Ippoliti, C.1
  • 8
    • 79953069895 scopus 로고    scopus 로고
    • [Package Insert], Janssen Pharmaceutica, Titusville, NJ: Author
    • Janssen Pharmaceutica. (1998). Loperamide [Package insert]. Titusville, NJ: Author.
    • (1998) Loperamide
  • 10
    • 51649105187 scopus 로고    scopus 로고
    • Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: A consensus statement by the Canadian Working Group on chemo- therapy-induced diarrhea
    • Maroun, J.A., Anthony, L.B., Blais, N., Burkes, R., Dowden, S.D., Dranitsaris, G., et al. (2007). Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: A consensus statement by the Canadian Working Group on chemo- therapy-induced diarrhea. Current Oncology, 14(1), 13-20.
    • (2007) Current Oncology , vol.14 , Issue.1 , pp. 13-20
    • Maroun, J.A.1    Anthony, L.B.2    Blais, N.3    Burkes, R.4    Dowden, S.D.5    Dranitsaris, G.6
  • 12
    • 17844397579 scopus 로고    scopus 로고
    • McCallum, P.D., & Polisena, C.G. (Eds.), Chicago: American Dietetic Association
    • McCallum, P.D., & Polisena, C.G. (Eds.). (2000). The clinical guide to oncology nutrition. Chicago: American Dietetic Association.
    • (2000) The Clinical Guide to Oncology Nutrition
  • 14
    • 79953662534 scopus 로고    scopus 로고
    • ONS PEP (Putting Evidence into Practice) weight of evidence classification schema: Decision rules for summative evaluation of a body of evidence
    • (n.d.) Retrieved May 7, 2009, from
    • Mitchell, S.A., & Friese, C.R. (n.d.). ONS PEP (Putting Evidence Into Practice) weight of evidence classification schema: Decision rules for summative evaluation of a body of evidence. Retrieved May 7, 2009, from http://www.ons.org/outcomes/tables/sleep/woe.shtml
    • Mitchell, S.A.1    Friese, C.R.2
  • 15
    • 0034211336 scopus 로고    scopus 로고
    • Testing control of radiation-induced diarrhea with a psyllium bulking agent: A pilot study
    • Murphy, J., Stacey, D., Crook, J., Thompson, B., & Panetta, D. (2000). Testing control of radiation-induced diarrhea with a psyllium bulking agent: A pilot study. Canadian Oncology Nursing Journal, 10(3), 96-100.
    • (2000) Canadian Oncology Nursing Journal , vol.10 , Issue.3 , pp. 96-100
    • Murphy, J.1    Stacey, D.2    Crook, J.3    Thompson, B.4    Panetta, D.5
  • 16
    • 33646783722 scopus 로고    scopus 로고
    • National Cancer Institute, [v3.0], Retrieved November 13, 2007, from
    • National Cancer Institute. (2006). Common terminology criteria for adverse events [v3.0]. Retrieved November 13, 2007, from http:// ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf
    • (2006) Common Terminology Criteria For Adverse Events
  • 17
    • 21344435247 scopus 로고    scopus 로고
    • The assessment and management of cancer treatment-related diarrhea
    • O'Brien, B.E., Kaklamani, V.G., & Benson, A.B., III. (2005). The assessment and management of cancer treatment-related diarrhea. Clinical Colorectal Cancer, 4(6), 375-381.
    • (2005) Clinical Colorectal Cancer , vol.4 , Issue.6 , pp. 375-381
    • O'Brien, B.E.1    Kaklamani, V.G.2    Benson III, A.B.3
  • 18
    • 4043152968 scopus 로고    scopus 로고
    • Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies
    • Rosenoff, S. (2004). Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies. Supportive Care in Cancer, 12(8), 561-570.
    • (2004) Supportive Care in Cancer , vol.12 , Issue.8 , pp. 561-570
    • Rosenoff, S.1
  • 19
    • 33746960799 scopus 로고    scopus 로고
    • A multicenter, randomized trial of long- acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: Results of the STOP trial
    • Rosenoff, S.H., Gabrail, N.Y., Conklin, R., Hohneker, J.A., Berg, W.J., Warsi, G., et al. (2006). A multicenter, randomized trial of long- acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: Results of the STOP trial. Journal of SupportiveOncology, 4(6), 289-294.
    • (2006) Journal of SupportiveOncology , vol.4 , Issue.6 , pp. 289-294
    • Rosenoff, S.H.1    Gabrail, N.Y.2    Conklin, R.3    Hohneker, J.A.4    Berg, W.J.5    Warsi, G.6
  • 20
    • 33846840609 scopus 로고    scopus 로고
    • Diarrhea: Applying research to bedside practice
    • Sabol, V.K., & Carlson, K.K. (2007). Diarrhea: Applying research to bedside practice. AACN Advanced Critical Care, 18(1), 32-44.
    • (2007) AACN Advanced Critical Care , vol.18 , Issue.1 , pp. 32-44
    • Sabol, V.K.1    Carlson, K.K.2
  • 21
    • 33947116528 scopus 로고    scopus 로고
    • Psyllium as therapeutic and drug delivery agent
    • Singh, B. (2007). Psyllium as therapeutic and drug delivery agent. International Journal of Pharmaceutics, 334(1-2), 1-14.
    • (2007) International Journal of Pharmaceutics , vol.334 , Issue.1-2 , pp. 1-14
    • Singh, B.1
  • 22
    • 35348870651 scopus 로고    scopus 로고
    • Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma
    • Topkan, E., & Karaoglu, A. (2006). Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology, 71(5-6), 354-360.
    • (2006) Oncology , vol.71 , Issue.5-6 , pp. 354-360
    • Topkan, E.1    Karaoglu, A.2
  • 23
    • 0035050218 scopus 로고    scopus 로고
    • Results of a double-blind, randomized study to evaluate the efficacy and safety of antibiophilus in patients with radiation-induced diarrhoea
    • Urbancsek, H., Kazar, T., Mezes, I., & Neumann, K. (2001). Results of a double-blind, randomized study to evaluate the efficacy and safety of antibiophilus in patients with radiation-induced diarrhoea. European Journal of Gastroenterology and Hepatology, 13 (4), 391-396.
    • (2001) European Journal of Gastroenterology and Hepatology , vol.13 , Issue.4 , pp. 391-396
    • Urbancsek, H.1    Kazar, T.2    Mezes, I.3    Neumann, K.4
  • 24
    • 84963796749 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, n.d, Retrieved November 15, 2007, from
    • U.S. Food and Drug Administration. (n.d.). WHO toxicity criteria by grade. Retrieved November 15, 2007, from http://www.fda.gov/cder/cancer/toxicityframe.htm
    • WHO Toxicity Criteria By Grade
  • 26
    • 0035104754 scopus 로고    scopus 로고
    • Octreotide in the treatment of severe chemotherapy-induced diarrhea
    • Zidan, J., Haim, N., Beny, A., Stein, M., Gez, E., & Kuten, A. (2001). Octreotide in the treatment of severe chemotherapy-induced diarrhea. Annals of Oncology, 12(2), 227-229.
    • (2001) Annals of Oncology , vol.12 , Issue.2 , pp. 227-229
    • Zidan, J.1    Haim, N.2    Beny, A.3    Stein, M.4    Gez, E.5    Kuten, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.